The following is a summary of "Preoperative Chemoradiotherapy for Resectable Gastric Cancer," published in the September 2024 ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read ...

Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

The following is a summary of “A modified GLIM criteria-based nomogram for the survival prediction of gastric cancer patients ...

Adding preoperative chemoradiotherapy to perioperative chemotherapy failed to boost survival, versus perioperative ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...

Keytruda cuts risk of death by 20% in certain patients with gastric or gastroesophageal junction as a first-line combination ...

The American Association for Cancer Research's latest Cancer Progress Report highlights the risk posed by several viral and ...

In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...